VistaGen Therapeutics Inc.

VistaGen Therapeutics Inc.

World Rank (Jan-05-2024)
19,787
Market Cap (Jan-05-2024)
0.138 Billion USD
World Rank (Jul-30-2023)
30,581
Market Cap (Jul-30-2023)
0.014 Billion USD
World Rank (Jan-07-2022)
15,666
Market Cap (Jan-07-2022)
0.351 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
VTGN
Market Cap (Mar-08-2026)
0.02
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
VISTAGEN THERAPEUTICS, INC.
Company Profile
VistaGen Therapeutics, Inc. is a Biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders. The company total assets are 108 million USD 2021. The headquarters is in USA.
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share